Biotechnology
ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of attention deficit hyperactivity disorder (ADHD). This milestone represents a substant...
2025-03-24 09:00
3655
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administrati...
2025-03-24 08:00
3126
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
* EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. * Preclinical highlights： * EVM14 induced a dose-dependent, antigen-specific immun...
2025-03-24 07:30
2957
Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up
SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period endingDecember 31, 2024, along with several significant milestones achieved in recent months. Dr. Jay Mei, Antengene's Founder,...
2025-03-21 19:29
5018
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure Data from Multiple Ongoing Late-Stage Studies Reinforce Brii Bio's HBV Functional Cure Strategy of Optimized Combination Regimens to Target...
2025-03-21 19:10
6918
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces thatthe United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, ki...
2025-03-21 08:38
2928
New Study Reveals NatureKnit™, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified Fibers
MOMENCE, Ill., March 20, 2025 /PRNewswire/ -- New research published in Microorganisms has revealed the significant impact of NatureKnit™, an all-natural and patent-pending gut health innovation from FutureCeuticals, on the human gut microbiome. The study, conducted in partnership with ProDigest...
2025-03-20 20:00
2866
Bened Life Leads Advocacy Campaign Alongside Research Innovation During Neurodiversity Celebration Week
FREMONT, Calif., March 20, 2025 /PRNewswire/ -- Bened Life, a pioneering biotechnology company dedicated to advancing mental and neurological health, is announcing an international donation campaign during Neurodiversity Celebration Week. As part of its commitment to fostering innovative solution...
2025-03-20 14:00
3493
BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China
Enhancing Precision and Innovation in Neurosurgical Robotics Across China ZHUBEI, March 20, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac ...
2025-03-20 11:16
2901
Pearl Partners with Medit to Enhance AI-Powered Dental Diagnostics in Intraoral Scanning and Medit Link Software Platform
By integrating Pearl's AI-powered diagnostic solutions with Medit Link, dental clinicians will gain access to advanced diagnostic support and enhanced communication tools that would improve clinical outcomes and patient experiences SEOUL, South Korea and LOS ANGELES, March 20, 2025 /PRNewswire/ -...
2025-03-20 09:00
3568
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody (mAb) for the treatment of gastric cancer. Re...
2025-03-19 23:17
2749
Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific
FREMONT, Calif., March 19, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established i...
2025-03-19 21:59
3434
Patricia Industries' subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
NORWOOD, Mass., March 19, 2025 /PRNewswire/ -- Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innov...
2025-03-19 21:55
2121
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody (mAb) for the treatment of gastric cancer. Ac...
2025-03-19 21:00
2820
Lynx Analytics Unveils LynxKite 2000:MM - The Next Generation of GPU-Optimized Graph AI
LOS GATOS, Calif., March 19, 2025 /PRNewswire/ -- Lynx Analytics, a member of
theNVIDIA Inception
2025-03-19 21:00
2402
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
IRVINE, Calif., March 19, 2025 /PRNewswire/ -- Zymo Research Corporation acknowledges the recent ruling, onMarch 14, 2025, by the United States District Court for the Central District ofCalifornia in the ongoing litigation with QIAGEN GmbH. The Court has denied QIAGEN's Partial Motion to Dismiss ...
2025-03-19 19:00
2048
DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
NEW YORK, March 19, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named toFast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses that are shaping research, industry, and the human condition through their unique...
2025-03-19 05:45
2986
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOP...
2025-03-18 21:00
2353
Medit Launches a New All-on-X Solution, Medit SmartX
SEOUL, South Korea and NEWPORT BEACH, Calif., March 18, 2025 /PRNewswire/ --
Medit (www.medit.com
2025-03-18 15:00
3384
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 18, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milest...
2025-03-18 11:00
3143
Week's Top Stories
Most Reposted
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 298 media titles]
2026-06-04 23:55
DayOne Appoints Nicolas Aguzin to Board of Directors, Strengthening Global Governance and Capital Markets Expertise
[Picked up by 281 media titles]
2026-05-29 15:50Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Creality 3D Successfully Listed in Hong Kong
[Picked up by 271 media titles]
2026-05-29 11:21
PHOTO & IMAGE SHANGHAI 2026 to Showcase AI Imaging, Content-Creation Technologies and Emerging Visual Trends This July
[Picked up by 269 media titles]
2026-05-29 17:36
Most Read
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
2026-05-30 11:58
8316
AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million
2026-05-29 21:50
7670
Creality 3D Successfully Listed in Hong Kong
2026-05-29 11:21
7261
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 22:00
6761